UnratedDrug recall · FDA · Published March 11, 2020
Jubilant Cadista Pantoprazole Tablets Recall: Dark Brown Tablet Edges
Jubilant Cadista recalls 40mg Pantoprazole tablets with dark brown discoloration on edges. Affected lots manufactured in India, expiring 2020-2021. No remedy specified in official notice.
“Jubilant Cadista Pantoprazole Tablets Recall: Dark Brown Tablet Edges.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37335-jubilant-cadista-pantoprazole-tablets-recall-dark-brown-tablet-edges. Based on FDA recall #D-1058-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1058-2020%22&limit=1).
Jubilant Cadista Pharmaceuticals, Inc. voluntarily recalled Pantoprazole Sodium Delayed-Release Tablets on March 11, 2020, due to CGMP deviations causing dark brown discoloration on tablet edges, the FDA said. The recall affects 89,376 bottles distributed nationwide.
The FDA reported that the tablets exhibited CGMP deviations characterized by the presence of dark brown discoloration on their edges.
Context
GovInfoNow's records show Jubilant Cadista Pharmaceuticals, Inc. has had 24 other recalls since Feb. 11, 2013. Recent brand recalls include a Dec. 27, 2022, Prochlorperazine recall for subpotent drug risk and a July 18, 2022, Irbesartan recall due to failed dissolution specifications. Other recent recalls of similar products include Hetero Labs Pantoprazole Tablets Recall (March 26, 2026) and Sun Pharmaceutical Carbamazepine Tablets Recall (Aug. 3, 2026).
How to tell if you have this one
Check for dark brown discoloration on the edges of 40mg Pantoprazole tablets. The affected lots were manufactured in India with specific lot numbers and expiration dates listed in the recall notice.
Brand
Jubilant Cadista
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Tablet Edges
Look for dark brown discoloration on the edges of the tablets.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Distributed Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 3 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1058-2020 (March 11, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1058-2020 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.